4782.0000 -23.00 (-0.48%)
NSE Jun 19, 2025 14:51 PM
Volume: 46,108
 

4782.00
-0.48%
Axis Direct
Alkem's domestic formulations business (76% of sales) grew 15% YoY (grew 22% YoY adj for excise duty impact, realization gap under GST) led by channel restocking. Gross margin improved 118 bps YoY, while EBITDA margin improved 574 bps driven by operating leverage.
Number of FII/FPI investors increased from 524 to 535 in Mar 2025 qtr.
More from Alkem Laboratories Ltd.
Recommended